• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Variations on hormone replacement therapy: an answer to the 'one dose fits all' Women's Health Initiative study.

作者信息

Studd John

机构信息

The London PMS and Menopause Centre, London, UK.

出版信息

Gynecol Endocrinol. 2007 Nov;23(11):665-71. doi: 10.1080/09513590701671878.

DOI:10.1080/09513590701671878
PMID:17943531
Abstract

The Women's Health Initiative study worked on the assumption that one dose would fit all asymptomatic postmenopausal women. The investigators therefore often used the wrong dose, of the wrong hormones, on the wrong patients and therefore came to many wrong conclusions. Different combinations of different hormones are necessary for different symptoms and different age groups. Hormone replacement therapy may be commenced in the perimenopausal phase, the early postmenopause, the late postmenopause or after hysterectomy and bilateral salpingo-oophorectomy or a premature menopause. These all require different treatments. Similarly, various indications such as vasomotor symptoms, sexual problems, depression or the treatment/prevention of osteoporosis all need different combinations of estradiol and possibly progestogen and testosterone, according to the specific requirements of the patient.

摘要

相似文献

1
Variations on hormone replacement therapy: an answer to the 'one dose fits all' Women's Health Initiative study.
Gynecol Endocrinol. 2007 Nov;23(11):665-71. doi: 10.1080/09513590701671878.
2
Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.雌激素争议结束了吗?剖析妇女健康倡议研究:对证据的批判性评估。
Ann N Y Acad Sci. 2005 Jun;1052:43-56. doi: 10.1196/annals.1347.004.
3
Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.特邀评论:激素治疗的风险与益处——妇女健康倡议研究结果及绝经后雌激素时机假说
Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25.
4
Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.连续联合激素替代疗法对绝经后早期女性的疗效及耐受性
Menopause Int. 2007 Sep;13(3):124-31. doi: 10.1258/175404507781605596.
5
Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.妇女健康倡议研究对泰国更年期诊所就诊女性的激素替代疗法态度及接受度的影响。
J Med Assoc Thai. 2007 Apr;90(4):628-35.
6
Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.激素替代疗法与心脏保护:新的曙光?意大利心脏病学会女性心血管疾病研究小组关于绝经后女性激素替代疗法的声明
J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):85-92. doi: 10.2459/JCM.0b013e328313e979.
7
Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.连续联合激素替代疗法可缓解绝经后早期女性的更年期症状并改善健康相关生活质量。
Menopause Int. 2007 Sep;13(3):116-23. doi: 10.1258/175404507781605622.
8
Menopausal hormone replacement therapy.更年期激素替代疗法
Curr Womens Health Rep. 2003 Oct;3(5):410-7.
9
Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.1997 - 2003年意大利更年期诊所就诊女性激素治疗使用决定因素的趋势
Menopause. 2008 Jan-Feb;15(1):164-70. doi: 10.1097/gme.0b013e318057782b.
10
Women's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative study.妇女健康倡议研究之后女性对激素替代疗法的态度。
J Adv Nurs. 2006 Jun;54(5):572-84. doi: 10.1111/j.1365-2648.2006.03862.x.